United Therapeutics Chairperson, CEO Martine Rothblatt disposes of USD 4.88 million in common shares

Bitget2026/10/08 21:29

United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 117.76 on Oct. 7, 2026. Family trust sales totaled 9,500 shares on Oct. 7 at weighted-average prices from USD 542.7339 to USD 556.4848. Trust holdings ended at 324,443 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000159), on October 08, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Dow Jones Top Company Headlines at 3 PM ET: Tesla's New Roadster Takes Flight After Nearly a Decade of Delays | CoreWeave ...

Dow Jones•2026/10/16 19:00

Coca-Cola FEMSA Shares Rise After JPMorgan Upgrade

MT newswire•2026/10/16 18:41

Bank of Canada: Inflation-growth tradeoff keeps policy on hold – RBC

FXStreet•2026/10/16 18:39

Data: If ETH breaks above $2,537, the cumulative short liquidation intensity on major CEXs will reach $862 millions.

Chaincatcher•2026/10/16 18:37